279 results
Top abstracts of AICT-AsiaPCR 2023
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore the cutting-edge research showcased in the top abstracts of AICT-AsiaPCR 2023, featuring insights on CT-based valve sizing for TAVR in bicuspid aortic stenosis and the impact of bleeding events post-TAVI on long-term mortality.
Challenges in calcified lesions
21 Sep 2023 – From AICT-AsiaPCR 2023
Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...
Coronary Atherosclerosis Phenotypes in Focal and Diffuse Disease
16 Aug 2023
This multicenter, prospective, single-arm study determined that Focal CAD had a higher plaque burden and was predominantly lipid-rich with a high prevalence of TCFA, whereas calcifications were more prevalent in diffuse CAD.
Reviewer
PCRonline @ ESC Congress 2023: the interventional cardiology perspective!
07 Aug 2023
What was new and hot in interventional cardiology at #ESCCongress 2023!
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation
24 Jul 2023
The aim of the REVASC-TAVI study was to compare different PCI timing strategies in patients with AS and significant CAD undergoing TAVI.
Reviewer
Reviewer
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation
27 Aug 2023
Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial
Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.
Note the assumptions in this article are based on the presentation...
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial
12 Jul 2023
This is a trial aiming to assess QFR and 3D-QCA DS% of all the non-infarct related arteries (IRA) with 3D-QCA DS% in all patients presenting with STEMI/NSTEMI and undergoing coronary angiography.
Reviewer
Reviewer
Should we perform revascularisation in patients with depressed left ventricle ejection fraction?
17 May 2023 – From EuroPCR 2023
Divaka Perera, main author of the REVIVED study, discusses the results of this trial with Flavio Ribichini.
REVIVE was a trial of severe ischaemic cardiomyopathy in which the primary outcome was death or heart failure hospitalization.The headline result was that there was absolutely no difference with PCI,...
Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled analysis of 4 randomized clinical trials
05 Jul 2023
This patient-level analysis of randomized trials comparing PCI vs CABG for the treatment of low-to-intermediate CAD involving the LM confirms the absence of long-term differences in mortality between revascularization techniques, regardless of the clinical presentation.
Reviewer
Reviewer
